2LM-16474-61741
2 vaccinations
1 coded response
1 check-in
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 103 / NY
- Registered
- 2021-12-17
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-01-26
Dose 1 — Moderna
-
2021-02-08
Dose 2 — Moderna
-
2021-12-17
Registered in v-safe
-
2022-02-08
Survey response — 12 months, dose 2MedDRA: COVID-19, Stillbirth — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, HospitalizationFree text: Pregnancy and subsequent stillbirth. COVID in December of 2021.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-08
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Hospitalization · 1 call case(s)
- 2022-02-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-26 | Moderna | No |
| 2 | 2021-02-08 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-08 | Unsuccessful |
Free text
Release 11 — 12 months, dose 2
Symptoms: Pregnancy and subsequent stillbirth. COVID in December of 2021.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Stillbirth | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release